IFNγ-producing iNKTs restrict a live-attenuated chlamydia oral vaccine in the large intestine - Summary - MDSpire

IFNγ-producing iNKTs restrict a live-attenuated chlamydia oral vaccine in the large intestine

  • By

  • Ahmed Mohamed Abdelsalam

  • Yi Wu

  • Mitchell Kronenberg

  • Huizhou Fan

  • Guangming Zhong

  • June 1, 2026

  • 0 min

Share

Objective:

To identify immune components responsible for preventing persistence of the live-attenuated chlamydia oral vaccine intrOv in the large intestine.

Key Findings:
  • Mice deficient in lymphocytes allowed intrOv to persist.
  • Invariant NKTs (iNKTs) producing IFNγ were identified as the key lymphocyte subset responsible for inhibiting intrOv persistence.
  • Adoptive transfer of wild-type iNKTs into deficient mice prevented intrOv persistence.
Interpretation:

The study reveals a role for IFNγ-producing iNKTs in preventing persistence of the live-attenuated chlamydia oral vaccine intrOv.

Limitations:
  • The study focused on mouse models, which may not fully replicate human immune responses.
  • The mechanisms by which iNKTs inhibit intrOv persistence require further investigation.
Conclusion:

The role of iNKTs in regulating intrOv persistence is discussed.

Original Source(s)

IFNγ-producing iNKTs restrict a live-attenuated chlamydia oral vaccine in the large intestine

  • by Ahmed Mohamed Abdelsalam, Yi Wu, Mitchell Kronenberg, Huizhou Fan, Guangming Zhong

  • June 1, 2026

Related Content

HPV-specific innovations and controversies in therapeutic strategies for HPV-associated oropharyngeal carcinoma

Caries May May Signal Oral Antibiotic Resistance

Study found species-specific differences in biofilm -forming capacity and antimicrobial susceptibility among supragingival bacterial isolates from patients with active dental caries.

Which vaccines will curb the Ebola outbreak? WHO debates